The Moulder Center for Drug Discovery Research was founded with a generous gift from School of Pharmacy alumni Mr. Lonnie Moulder and his wife, Sharon, both were graduates of the Class of 1980. In 2008, the School of Pharmacy recruited a distinguished drug discovery leader to spearhead the center’s efforts. Dr. Magid Abou-Gharbia, a Laura H. Carnell Professor at Temple University School of Pharmacy and a well-known leader in the field of drug discovery, was the Moulder Centers director for 12 years (2008-2020). Prior to joining Temple University’s Moulder Center, Dr. Abou-Gharbia was Senior Vice President of Discovery Research at Wyeth Pharmaceuticals. Dr, Daniel J Canney assumed the role of interim director in July, 2020. In 2010, Temple University increased its commitment to the Moulder Center by providing a Drug Discovery Initiative fund. This support by the office of the Provost allowed the Moulder Center to significantly expand its capabilities and add key personnel. In 2015, Lonnie and Sharon Moulder provided a $4 million endowment to the Moulder Center to support additional expansion and future scientific initiatives. In 2019, the Moulder Center entered its 10th year of operation. Over the course of that time, the Moulder Center has been awarded multiple grants from the NIH and private foundations. In addition, multiple biotechnology start-up companies have been founded based on science developed at the Moulder Center.
Moulder Center for Drug Discovery Research
Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140